文献速递自身炎症与 IgG4 相关病

MRP8/14血清水平作为儿童长期发热中系统性幼年特发性关节炎的诊断标志物

MRP8/14 serum levels as diagnostic markers for systemic juvenile idiopathic arthritis in children with prolonged fever.
PubMed 文献 · Rheumatology (Oxford) · 2022-01-01

该研究纳入1110例儿科患者,分两个队列验证MRP8/14在发热儿童中诊断系统性幼年特发性关节炎(SJIA)的价值,并与感染及自身炎症性疾病鉴别。结果显示SJIA患者MRP8/14显著升高,且商业ELISA和侧向流免疫分析(LFIA)均能确认其诊断准确性,优于铁蛋白、IL-18等指标。

要点

  • MRP8/14在SJIA患儿中显著升高,不受发热及抗炎治疗影响。
  • 未治疗发热患儿中,MRP8/14诊断SJIA的敏感度73%、特异度90%。
  • LFIA快速床旁筛查敏感度84%、特异度81%,优于传统标志物。

核心结论

  • MRP8/14血清检测可辅助儿童长期发热中SJIA的诊断,商业ELISA与LFIA均能验证其准确性。

研究设计与样本

  • 纳入1110例儿科患者,分队列A(n=940)验证三种检测系统性能,队列B验证后两种检测系统的诊断准确性。

主要发现

  • 队列B1未治疗发热患者(n=170)中,商业ELISA敏感度79%、特异度89%,LFIA敏感度84%、特异度81%。
  • 与铁蛋白、IL-18、ESR、可溶性IL-2受体和降钙素原相比,MRP8/14准确度最高。

关键数值与推荐

  • 未治疗发热患儿中MRP8/14诊断SJIA的敏感度73%、特异度90%(队列A,n=195)。
  • 商业ELISA敏感度79%、特异度89%,LFIA敏感度84%、特异度81%(队列B1,n=170)。

临床怎么用

  • 对长期发热儿童,可检测MRP8/14辅助鉴别SJIA与感染性疾病。
  • LFIA可作为快速床旁筛查工具,支持早期诊断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Differential diagnosis in children with prolonged fever is challenging. In particular, differentiating systemic-onset JIA (SJIA) from infectious diseases is difficult. Biomarkers are needed that support the diagnostic work-up. The aim of this study was to validate the usefulness of Myeloid-related protein 8/14 (MRP8/14) measurements in the diagnostic work-up of febrile children and to transfer it to clinical practice. METHODS: Data for 1110 paediatric patients were included and divided into two cohorts: (cohort A) for validation of MRP8/14 test performance with three different testing systems: the experimental ELISA, commercial ELISA and an innovative (point-of-care test) lateral flow immunoassay (LFIA); (cohort B) to validate the diagnostic accuracy with the two latter assays. RESULTS: In cohort A (n = 940), MRP8/14 was elevated in SJIA (12 110 ± 2650 ng/ml mean ± 95% CI) compared with other diagnoses (including infections and autoinflammatory diseases; 2980 ± 510 ng/ml) irrespective of fever and anti-inflammatory treatment (P < 0.001). In untreated patients with fever (n = 195) MRP8/14 levels in SJIA (19 740 ± 5080 ng/ml) were even higher compared with other diagnoses (4590 ± 1160 ng/ml) (P < 0.001, sensitivity 73%, specificity 90%). In group B1, the performance of the tests was confirmed in untreated patients with fever (n = 170): commercial ELISA (sensitivity 79%, specificity 89%) and LFIA (sensitivity 84%, specificity 81%). Compared with ferritin, IL-18, ESR, soluble IL-2 receptor and procalcitonin, MRP8/14 showed the best accuracy. CONCLUSION: MRP8/14 serum analyses have been validated as a helpful tool supporting the diagnosis of SJIA in febrile children. The results could be confirmed with commercial ELISA and LFIA enabling a rapid diagnostic point-of-care screening test.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Park C, Miranda-Garcia M, Berendes R, et al. MRP8/14 serum levels as diagnostic markers for systemic juvenile idiopathic arthritis in children with prolonged fever. Rheumatology (Oxford). 2022. PMID: 34559193. doi:10.1093/rheumatology/keab729

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。